With growing demand for GLP-1s, their supply chain integrity is vital. This article shows how EU Good Distribution Practice (GDP) and data operations (DataOps) help people manage these temperature-sensitive medicines in Europe. GLP-1s: Temperature Control GLP-1 drugs, for diabetes and obesity, are showing promise for other conditions, increasing demand. Global sales hit $53.6B (approximately £42.34B […]
I was recently asked to travel to a country that was adjacent to a newly erupted war zone – missiles were raining down relatively nearby. The country I was visiting also has some stringent restrictions on travelling with medication (I’m a diabetic) so I was already somewhat apprehensive (even having been before!). The company sending
As the Maly IT team, we understand the benefits of adopting good practices in the pharmaceutical industry. Ever mindful that the health and well-being of individuals depends on the quality, safety, and efficacy of medicinal products. Therefore, we agree that helping our customers to assure adherence to stringent guidelines and regulations is paramount. What are
Artificial Intelligence (AI) is up ending the recruitment business model, automating everything from sourcing and screening to candidate engagement and assessment. However, as we saw in Part 1 organisations embracing these tools must also navigate an increasingly complex web of regulations and ethical standards. The use of AI in recruitment significantly impacts compliance with laws
Recruitment is the gateway to every organisation’s talent and culture. But in today’s regulatory landscape, it’s not enough to simply find the right candidate; you must do so within a framework of strict compliance. This is becoming more complex than ever, especially as organisations increasingly rely on contractors and freelancers. Navigating this landscape requires not
As demand for Glucagon-like peptide-1 (GLP-1) therapies grows, maintaining their integrity across the international supply chain is a complex logistical challenge. It requires meticulous cold chain management to prevent spoilage and to safeguard patient outcomes. This article aims to focus on managing temperature excursions for a specific category of products. It expands on a previous
Escalating demand for temperature-sensitive biologics, vaccines, and advanced therapies intensifies the challenge of maintaining stringent temperature control throughout the entire distribution network, argues Richard Maly. The Imperative of Temperature Control Temperature excursions are defined as any deviation from a pharmaceutical product’s specified temperature range during its storage, transport, or handling, as determined by the manufacturer’s
Our regular readers will know Maly is a company which specialises in helping innovators simplify, digitise, automate and control complex industrial and compliance processes. The Okuda no-code tool allows users to model and capture any process as a series of simple digital steps, ensuring each individual and team plays their part at the right time
Norfolk Hospital Joins Groundbreaking Generation Study Here at Maly IT, we’re really pleased to hear that our local Norfolk and Norwich University Hospital (NNUH) is taking part in the pioneering Generation Study. This national research project aims to transform how over 200 rare genetic conditions are diagnosed in newborns. The study will offer whole genome
Building upon Part 1’s exploration of product labelling as a defence against counterfeiting, this article (Part 2) delves into the intricate process of managing pharmaceutical labelling changes, crucial for compliance, minimising waste, and maintaining efficient supply chains across multiple markets. The seemingly simple act of changing a word or updating a logo on a pharmaceutical
